Concepedia

Jun Li

JL

Statistics

Publications

23

Citations

738

H-Index

17

Active since

2000

Affiliations

Bristol-Myers Squibb (United States)(Current)

Anhui Medical University

Beth Israel Deaconess Medical Center

Bristol-Myers Squibb (Germany)

Dana-Farber Cancer Institute

Jun Li is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and pharmacy.

ORCID

Publications per year

2000–2024

23

Publications

23

A Pilot Study of the FRAIL Scale on Predicting Outcomes in Chinese Elderly People With Type 2 Diabetes

Ying Li, Yupei Zou, Shuang Wang et al. · Journal of the American Medical Directors Association · 2015 · 105 citations

, , +16

High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling

Liucheng Li, Delin Li, Liang Xu et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 70 citations

, , +15

Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma

Sarah M. Bronner, Karl A. Merrick, Jeremy Murray et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 64 citations · Full text

, , +11

Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA<sub>1</sub>) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases

Peter T. W. Cheng, Robert F. Kaltenbach, Hao Zhang et al. · Journal of Medicinal Chemistry · 2021 · 57 citations · Full text

, , +8

Discovery of an Oxybenzylglycine Based Peroxisome Proliferator Activated Receptor α Selective Agonist 2-((3-((2-(4-Chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic Acid (BMS-687453)

Jun Li, Lawrence J. Kennedy, Yan Shi et al. · Journal of Medicinal Chemistry · 2010 · 41 citations · Full text

, , +17

1–5 of 23